William Philip Arthur, DPM
Podiatry · Fort Wayne
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Aboite Podiatry Associates PC · 3 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Arthur’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G5571 · Cancelled
Licence status: Cancelled · since 1959 · Boston University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$54,939
Medicare paid this office $54,939 for 286 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 168 | $19,387 | $61 |
| Removal of fingernails or toenails, 6 or more nails | 158 | $12,581 | $29 |
| New patient visit (30+ min) | 99 | $6,829 | $69 |
| Destruction of skin growth, 1-14 growths | 11 | $2,114 | $78 |
| Removal of tissue from wound, 20.0 sq cm or less | 15 | $2,064 | $74 |
See all 9 services
| Short return visit (20+ min) | 168 | $19,387 | $61 |
| Removal of fingernails or toenails, 6 or more nails | 158 | $12,581 | $29 |
| New patient visit (30+ min) | 99 | $6,829 | $69 |
| Destruction of skin growth, 1-14 growths | 11 | $2,114 | $78 |
| Removal of tissue from wound, 20.0 sq cm or less | 15 | $2,064 | $74 |
| Removal of noncancer thickened skin growth, 1 growth | 24 | $1,934 | $45 |
| X-ray of foot, minimum of 3 views | 46 | $1,710 | $22 |
| Removal of noncancer thickened skin growth, 2-4 growths | 16 | $1,624 | $51 |
| Simple separation of fingernail or toenail from nail bed, first nail | 11 | $757 | $69 |
Procedures Medicare counted
| Removal of nail tissue | 59 | More than 66% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
286 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 17% · Women 52% · Also on Medicaid 6% · Health risk score 1.50. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 50% · Chronic kidney disease 36% · Coronary heart disease 35% · Depression 25% · Heart failure 21% · COPD 17% · Atrial fibrillation 17% · Cancer 16% · Dementia 9% · Stroke 8%.
The office billed $91,480, Medicare allowed $76,536 and paid $54,939; for 1,152 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 286 | 1,152 | 76 | 1.50 | $91,480 | $54,939 |
| 2023 | 259 | 1,231 | 76 | 1.43 | $185,321 | $88,997 |
| 2022 | 212 | 927 | 75 | 1.41 | $136,952 | $69,286 |
| 2021 | 202 | 908 | 73 | 1.42 | $96,877 | $58,916 |
| 2020 | 65 | 131 | 73 | 1.10 | $20,658 | $7,660 |
| 2019 | 25 | 35 | 73 | 0.81 | $7,642 | $1,872 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Short return visit (20+ min) | 134 | $15,224 | $62 |
| New patient visit (30+ min) | 140 | $10,178 | $73 |
| Removal of fingernails or toenails, 6 or more nails | 136 | $9,547 | $29 |
| X-ray of foot, minimum of 3 views | 53 | $2,171 | $24 |
| Removal of noncancer thickened skin growth, 1 growth | 23 | $1,965 | $49 |
| Removal of noncancer thickened skin growth, 2-4 growths | 13 | $1,636 | $55 |
| Simple separation of fingernail or toenail from nail bed, first nail | 15 | $1,188 | $79 |
| Short return visit | 13 | $573 | $38 |
| Removal of fingernails or toenails, 1-5 nails | 17 | $480 | $23 |
2022: 9 services
| Short return visit (20+ min) | 89 | $10,461 | $62 |
| New patient visit (30+ min) | 119 | $8,549 | $72 |
| Removal of fingernails or toenails, 6 or more nails | 99 | $6,841 | $29 |
| Removal of noncancer thickened skin growth, 2-4 growths | 17 | $1,781 | $56 |
| X-ray of foot, minimum of 3 views | 38 | $1,444 | $24 |
| Short return visit | 29 | $1,215 | $35 |
| Removal of noncancer thickened skin growth, 1 growth | 12 | $1,145 | $46 |
| Removal of fingernails or toenails, 1-5 nails | 17 | $471 | $21 |
| Trimming of dystrophic nails, any number | 11 | $172 | $11 |
2021: 7 services
| New patient visit (30+ min) | 143 | $10,113 | $71 |
| Short return visit (20+ min) | 70 | $6,557 | $62 |
| Removal of fingernails or toenails, 6 or more nails | 71 | $4,359 | $33 |
| Biopsy of fingernail or toenail | 24 | $2,211 | $88 |
| X-ray of foot, minimum of 3 views | 53 | $2,129 | $24 |
| Short return visit | 29 | $1,650 | $41 |
| Removal of fingernails or toenails, 1-5 nails | 11 | $248 | $21 |
2020: 2 services
| New patient visit (30+ min) | 41 | $3,103 | $76 |
| Short return visit (20+ min) | 15 | $913 | $54 |
2019: 1 service
| Short return visit | 17 | $920 | $44 |
Drugs they prescribed that Part D paid
$3,844
Pharmacies billed $3,844 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
234 generic and fewer than 11 brand-name prescriptions · $3,844 in drug cost · 99 antibiotic prescriptions to 47 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Doxycycline Hyclate | 24 | $303 | $13 |
| Amoxicillin-Clavulanate Potass | 28 | $271 | $10 |
| Ammonium Lactate | 26 | $230 | $9 |
| Econazole Nitrate | 22 | $184 | $8 |
| Cephalexin | 24 | $182 | $8 |
See all 9 drugs
| Doxycycline Hyclate | 24 | $303 | $13 |
| Amoxicillin-Clavulanate Potass | 28 | $271 | $10 |
| Ammonium Lactate | 26 | $230 | $9 |
| Econazole Nitrate | 22 | $184 | $8 |
| Cephalexin | 24 | $182 | $8 |
| Methylprednisolone | 14 | $100 | $7 |
| Levofloxacin | 12 | $53 | $4 |
| Meloxicam | 27 | $46 | $2 |
| Allopurinol | 12 | $31 | $3 |
Year by year
| 2024 | 237 | 101 | None | None | $3,844 |
| 2023 | 325 | 125 | 6% (20) | 6% | $15,052 |
| 2022 | 216 | 101 | 7% (16) | 16% | $24,147 |
| 2021 | 179 | 85 | 10% (18) | 13% | $21,540 |
| 2020 | 16 | 11 | 69% (11) | 0% | $175 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Jublia | 11 | $8,656 | $787 |
| Amoxicillin-Clavulanate Potass | 48 | $689 | $14 |
| Doxycycline Hyclate | 53 | $671 | $13 |
| Econazole Nitrate | 16 | $527 | $33 |
| Ciclopirox | 11 | $373 | $34 |
| Ammonium Lactate | 21 | $267 | $13 |
| Methylprednisolone | 18 | $176 | $10 |
| Cephalexin | 19 | $168 | $9 |
| Levofloxacin | 21 | $162 | $8 |
| Mupirocin | 12 | $124 | $10 |
| Hydrocodone-Acetaminophen | 12 | $94 | $8 |
| Meloxicam | 30 | $64 | $2 |
2022: 9 drugs
| Jublia | 17 | $13,787 | $811 |
| Doxycycline Hyclate | 19 | $374 | $20 |
| Amoxicillin-Clavulanate Potass | 25 | $314 | $13 |
| Ammonium Lactate | 12 | $251 | $21 |
| Hydrocodone-Acetaminophen | 15 | $190 | $13 |
| Cephalexin | 22 | $172 | $8 |
| Methylprednisolone | 17 | $171 | $10 |
| Clindamycin | 13 | $159 | $12 |
| Meloxicam | 25 | $100 | $4 |
2021: 6 drugs
| Jublia | 16 | $12,082 | $755 |
| Ciclopirox | 16 | $457 | $29 |
| Hydrocodone-Acetaminophen | 18 | $220 | $12 |
| Amoxicillin-Clavulanate Potass | 23 | $186 | $8 |
| Clindamycin | 11 | $168 | $15 |
| Cephalexin | 20 | $116 | $6 |
Money from drug and device companies
$80 in 2025
| 2025 | 3 | 5 | None | $80 |
| 2024 | 11 | 17 | None | $757 |
| 2023 | 7 | 10 | None | $304 |
| 2022 | 12 | 38 | None | $1,095 |
| 2021 | 9 | 20 | None | $581 |
| 2020 | 4 | 5 | None | $215 |
| 2019 | 1 | 1 | None | $821 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Regranex | $52 | 3 payments
|
| Paragon 28 | Grappler | $15 | 1 payment
|
| Amgen | Krystexxa | $14 | 1 payment
|
See all 5 published payments
| Smith+Nephew | Meals · 2025-09-19 | Collagenase Santyl | $16 |
| Amgen | Meals · 2025-08-04 | Krystexxa | $14 |
| Smith+Nephew | Meals · 2025-05-30 | Regranex | $17 |
| Smith+Nephew | Meals · 2025-04-25 | Regranex | $18 |
| Paragon 28 | Meals · 2025-01-07 | Grappler | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $757
| Nevro | Senza | $154 | 2 payments
|
| Medtronic | Intellis Adaptivestim | $137 | 1 payment
|
| Boston Scientific | None | $128 | 1 payment
|
| Abbvie | Ubrelvy | $85 | 3 payments
|
| Smith+Nephew | Renasys | $69 | 3 payments
|
| Organogenesis | None | $54 | 2 payments
|
| Linvatec | Biobrace 23mm | $34 | 1 payment
|
| Averitas Pharma | Qutenza | $30 | 1 payment
|
| DePuy Synthes Sales | N/A | $26 | 1 payment
|
| Treace Medical Concepts | Lapiplasty System | $25 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $17 | 1 payment
|
2023: $304
| Boston Scientific | None | $131 | 1 payment
|
| Smith+Nephew | Grafix | $80 | 4 payments
|
| AbbVie | Dalvance | $27 | 1 payment
|
| Averitas Pharma | Qutenza | $23 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $19 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $15 | 1 payment
|
| Dynasplint Systems | Dynasplint | $9 | 1 payment
|
2022: $1,095
| Nevro | Omnia | $313 | 3 payments
|
| Smith+Nephew | Grafix Pl | $291 | 22 payments
|
| Boston Scientific | General - Vascular Intervention | $142 | 1 payment
|
| Medtronic | Intellis Adaptivestim | $123 | 1 payment
|
| Organogenesis | Puraply | $69 | 2 payments
|
| Treace Medical Concepts | Lapiplasty System | $53 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $30 | 2 payments
|
| Paratek Pharmaceuticals | Nuzyra | $18 | 1 payment
|
| Nabriva Therapeutics plc | Sivextro | $16 | 1 payment
|
| Acera Surgical | Restrata Wound Matrix | $15 | 1 payment
|
| Kowa Pharmaceuticals America | Seglentis | $13 | 1 payment
|
| Triad Life Sciences | Innovamatrix Ac | $12 | 1 payment
|
2021: $581
| Organogenesis | Puraply Antimicrobial | $255 | 7 payments
|
| Boston Scientific | General - Vascular Intervention | $122 | 1 payment
|
| GRT US Holding | Qutenza | $61 | 4 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $36 | 2 payments
|
| Anika Therapeutics | Tactoset | $32 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $29 | 2 payments
|
| Smith+Nephew | Grafix Pl | $19 | 1 payment
|
| Nabriva Therapeutics plc | Sivextro | $16 | 1 payment
|
| Alfasigma USA | None | $11 | 1 payment
|
2020: $215
| In2Bones USA | Colink | $115 | 1 payment
|
| DePuy Synthes Sales | Hammersplint | $46 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $41 | 2 payments
|
| Organogenesis | Puraply | $14 | 1 payment
|
2019: $821
| Evolution Surgical | None | $821 | 1 payment
|
Professional record
- NPI
- 1467803759
- Licence
- CA 5571California G5571: Cancelled
- Trained
- California School of Podiatric Medicine, 2016
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0000X (213ES0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-06-28
- NPI last updated
- 2020-06-03
- NPI record certified
- 2020-06-03
This is when the NPI record was last certified, not a medical board exam.